Podcast
Podcast with MedAsian
China healthcare policy landscape
Already have it? Open in the app
Latest episodes
- How Government Affairs Is Becoming a Core Driver of Healthcare Valuation29 Jun 2026
- Section 1260H decoded: How Chinese biotech builds trust in the U.S.17 Jun 2026
- Beyond the Deal: How Chinese Healthcare Companies Can Build Long-Term Success in the U.S.1 Jun 2026
- Views on the Trump visit to Beijing and outlook on US-China Bilateral relationship20 May 2026
- Innovation Is Easy, Governance Is Hard: AI’s Next Challenge in Healthcare (Part II)12 May 2026
- Innovation Is Easy, Governance Is Hard: AI’s Next Challenge in Healthcare (Part I)27 Apr 2026
- From Steel to Stem Cells: How a 1962 Cold War Trade Law Is Quietly Redrawing the Global Pharma Map (Part 2)15 Apr 2026
- From Steel to Stem Cells: How a 1962 Cold War Trade Law Is Quietly Redrawing the Global Pharma Map9 Apr 2026
- Policy advocacy, government relations, and bilateral investment opportunities in an evolving US-China landscape (Part 2)3 Apr 2026
- Policy advocacy, government relations, and bilateral investment opportunities30 Mar 2026